-
IntroducedJan 10, 2025
-
Passed Senate
-
Passed House
-
Signed into Law
AN ACT REQUIRING MEDICAID COVERAGE FOR BONE MARROW AND STEM CELL TRANSPLANTS AND FDA-APPROVED GENE THERAPIES TO TREAT SICKLE CELL DISEASE. To provide equitable access to life-changing medical advancements to treat sickle cell disease, ameliorate suffering and reduce long-term health care costs.
Last Action See all actions
Senate • Jan 10, 2025: Referred to Joint Committee on Human Services
Latest Bill Text See all bill texts
Official Summary/Bill Text
Comments on SB 439
Tweets
Whip Lists
Sponsors
Votes
Actions
- Jan 10, 2025 | Senate
- Referred to Joint Committee on Human Services
Bill Texts
Documents